Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and
Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and financial performance. Son joined Wuestec as president in 2000. Before then, he was in charge of strategic development at Gemini Consulting in New York.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.